David A. Waller
St Bartholomew's Hospital · 464 works · 25,089 citations · h-index 74
Top works
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Video-assisted thoracoscopic surgery versus thoracotomy for spontaneous pneumothorax
- British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE
- ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer☆
- Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
- ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer
- The Transfer of Spatial Knowledge in Virtual Environment Training
- Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
- The Frequency of Uniparental Disomy in Prader-Willi Syndrome
- Guidelines on the radical management of patients with lung cancer
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
- Individual Differences in Spatial Abilities
- A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients
- Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer
- ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax
- Maternal Deprivation Reassessed
- The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting